Brief: Atara Biotherapeutics Provides Regulatory And Business Updates On Tabelecleucel (Tab-Cel)
14/07/2025 13:13
July 14 (Reuters) - Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS PROVIDES REGULATORY AND BUSINESS UPDATES ON TABELECLEUCEL (TAB-CEL®) ATARA BIOTHERAPEUTICS INC - BLA APPROVAL TO TRIGGER $40 MILLION MILESTONE PAYMENT ATARA BIOTHERAPEUTICS INC - PROJECTS $22M CASH AND INVESTMENTS AS OF JUNE 2025 Source text: ID:nBwlM8kPa Further company coverage: ATRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing